Abstract
Sarcoptes scabiei is a permanent ectoparasite causing scabies in humans and sarcoptic mange in animals, resulting in significant health and economic impacts worldwide. Current treatments exhibit limited efficacy against eggs and molting mites, leading to treatment failures. Terpenes from essential oils, including carvacrol, eugenol, and geraniol, have previously shown notable acaricidal and ovicidal activity. In this study, molting Sarcoptes mites were exposed to 0.3% carvacrol, 0.9% eugenol, and 1.1% geraniol for 1 h, resulting in molt rates of 74%, 86%, and 88%, respectively, with carvacrol demonstrating superior efficacy (P < 0.001 vs. control). Further investigation revealed that exposure to 1% carvacrol over varying durations (1 ~ 5 h) achieved complete suppression of molting after 4 h, with a LT50 of 1.4 ± 0.4 h, which is significantly higher than active adult mites(LT50 of 3.45 min in prior research). Microscopic analysis demonstrated intra-corporeal droplets were observed within treated molting mites, which suggest that terpenes likely exert their effects by penetrating the cuticle of molting mites, and carvacrol exhibited greater cuticular penetration efficiency. This study provides foundational evidence for the therapeutic use of carvacrol in managing S. scabiei infestations and highlights the need for further research into its mechanisms of action and safety in veterinary and human applications.
Keywords: Sarcoptes scabiei, Molt process, Carvacrol, Terpenes
Introduction
Sarcoptes scabiei is a permanent and obligate ectoparasite that burrows and multiplies within the epidermis, causing scabies in humans and sarcoptic mange in numerous mammalian species worldwide [17]. The clinical manifestations of scabies in humans include intense pruritus, erythema, and secondary bacterial infections, which can lead to significant discomfort and reduced quality of life [10]. In livestock and wildlife, sarcoptic mange often results in severe dermatological lesions, weight loss, and compromised immunity, further affecting animal health and welfare [22]. Globally, scabies is estimated to affect 200–300 million people each year, disproportionately impacting populations in low-resource settings where overcrowding and limited access to healthcare facilitate its transmission [17].
In veterinary contexts, sarcoptic mange leads to substantial economic losses due to reduced productivity, including decreased growth rates, lower reproductive performance, and diminished feed efficiency in affected animals [2]. Moreover, mange outbreaks in wildlife can have devastating ecological consequences, especially in endangered species where high mortality rates threaten population viability [22]. These impacts underscore the need for effective control strategies in both human and veterinary settings.
Current treatment options for scabies include a variety of topical agents, such as 5% permethrin, 10–25% benzyl benzoate, crotamiton, 0.5% malathion, and oral ivermectin [30]. In veterinary medicine, chemical treatments primarily rely on macrocyclic lactones (e.g., moxidectin, doramectin, selamectin or eprinomectin) [7] and isoxazolines (e.g., afoxolaner, fluralaner or sarolaner) [5]. Despite their efficacy, these current treatments are associated with various side effects. For instance, benzyl benzoate frequently causes skin irritation, which can be particularly intense during the initial minutes after application. Ivermectin have been reported that severe drug eruption (toxic epidermal necrosis), nausea, and vomiting. In veterinary applications, studies have shown that overdose can induce acute toxicities in animals, such as convulsions [11]. While these treatments have demonstrated efficacy against motile mites, their activity against eggs is often limited [4]. Notably, molting mites, which transition from larvae to nymphs and then to adults, exhibit greater resistance to certain acaricides, such as ivermectin, compared to motile stage [9]. This resistance may contribute to incomplete treatment outcomes and the persistence of infestations, necessitating the exploration of novel therapeutic agents.
In recent years, growing concerns over the environmental and health impacts of synthetic acaricides have driven interest in natural alternatives. Essential oils, which are complex mixtures of bioactive compounds derived from plants, have gained attention as safer and environmentally friendly options for pest management [24]. Among their constituents, terpenes have been identified as key contributors to acaricidal activity. These compounds, which include monoterpenes such as carvacrol, eugenol, and geraniol, are known for their broad-spectrum antimicrobial, antifungal, and insecticidal properties [21].
In our previous studies, carvacrol, eugenol, and geraniol were found to exhibit significant acaricidal activity against Sarcoptes mites and their eggs [18, 19]. These findings highlight the potential of terpenes as alternative therapeutic agents for managing scabies infestations. Despite this progress, the efficacy of these compounds against molting mites remains unexplored. Given that the molting stage is a critical developmental stage, investigating the activity of terpenes during this phase is of importance.
This study evaluated the efficacy of carvacrol, eugenol, and geraniol against molting Sarcoptes mites, aiming to provide a scientific foundation for the potential therapeutic use of terpenes in the management of scabies in both human and veterinary medicine.
Material and methods
Tested products
Carvacrol (Purity: 99%; CAS: 499–75-2), eugenol (Purity: 99%; CAS: 97–53-0), geraniol (Purity: 98%; CAS: 106–24-1), and liquid paraffin oil (AR 99%) were purchased from Shanghai Macklin Biochemical Company (Shanghai, China). Both terpenes and liquid paraffin oil were stored at 4 °C in the dark prior to use.
Collections of mites
Crust samples were collected from naturally infested New Zealand white rabbits on a farm in Nanning, Guangxi Province, China, with the informed consent of the farm owner. The crusts were collected from different body regions of these rabbits and transferred into 90 mm petri dishes and cut into approximately 25 mm3 smaller pieces using surgical scissors.
Molting mites were identified based on two criteria: the presence of an outer cuticle encasing the mite, and a complete lack of motility. Using a stereomicroscope (Nikon Corp.; SMZ745; 20 × magnification), individuals meeting both criteria were isolated with a needle. Mites undergoing any molting stage (larva to protonymph, protonymph to tritonymph, or tritonymph to adult) were included and randomly assigned to experimental replicates.
Assessment of terpenes activity
To assess and compare the efficacy of carvacrol, eugenol and geraniol against molting mites on an equi-effective basis, the minimum effective concentration (MEC) of each terpene required to achieve 100% mortality in female mites within 1 h was determined, following the bioassay protocol described by Li et al. [18]. Briefly, female mites (n = 10 per group with five replicates) were exposed to a series of terpene concentrations diluted in paraffin oil based on the previous results [18]. Mortality was evaluated at 1-h post-exposure, with death defined as the absence of movement after gentle prodding with a sterile probe. As a result, the minimum effective concentrations inducing 100% mortality within 1 h were 0.3% for carvacrol, 0.9% for eugenol, and 1.1% for geraniol.
The above concentrations (v/v paraffin oil) were then applied to molting Sarcoptes mites for 1 h. The bioassay protocol was the same as that for female mites mentioned above. Carvacrol, identified as the most effective terpene based on initial results, was selected for further evaluation. Since 1% carvacrol represents the maximum recommended dermal application level [31], molting mites were subsequently exposed to 1% carvacrol for intervals of 1, 2, 3, 4, and 5 h. After each exposure period, the mites were washed and transferred to a humidity chamber (35°C, 80% relative humidity) to observe the molting stage. Liquid paraffin oil served as the negative control, and a no-solvent control was included to assess solvent effects. Molting stage was evaluated after 48 h, mites failing to molt were classified as dead, according to the previous methodology [9]. Each treatment group used 10 mites per replicate, with five replicates conducted. Single repetition count was analyzed as independent blocks.
To assess morphological changes, molting mites were observed and photographed before and after treatment using a stereomicroscope (Nikon Eclipse 80i; 400 × magnification).
Data analysis
All statistical analyses were performed using SPSS software (version 22.0). Differences in molt rates among terpene treatment groups were evaluated using Fisher’s Exact Test, and the bootstrap method was used for calculating 95% Confidence Intervals (CIs). All statistical assumptions were validated prior to analysis. Values of P < 0.05 were considered significant. The median lethal time (LT₅₀) was calculated using probit regression analysis. Bar graphs were generated using GraphPad Prism software (version 10.4.1).
Results
Assessment of terpene activity
Exposure of molting Sarcoptes mites to 0.3% carvacrol, 0.9% eugenol, and 1.1% geraniol for 1 h resulted in molt rates of 74% (95%CI: 66%−78%), 86% (95%CI: 82%−94%), and 88% (95%CI: 72%−96%), respectively (Fig. 1). All mites treated with paraffin oil or no solvent molted successfully. Molt rates following 0.3% carvacrol treatment differed significantly from controls (P < 0.001). In contrast, 0.9% eugenol and 1.1% geraniol reduced molting compared to controls (P < 0.05), highlighting carvacrol's superior efficacy.
Fig. 1.

The molt rate of Sarcoptes mites after exposure to 0.3% carvacrol, 0.9% eugenol, or 1.1% geraniol for 1 h. The control group was treated with liquid paraffin. (***: P < 0.001; *: P < 0.05; ns: P > 0.05; error bar represent mean ± SD)
Assessment of carvacrol activity
Treatment duration with carvacrol had a significant effect on molt rate (Fisher exact test, P < 0.001). Exposure to 1% carvacrol for 1, 2, 3, 4, and 5 h produced molt rates (95% CI) of 64% (52%−74%), 24% (8%−40%), 12% (4%−28%), 0% and 0%, respectively (Fig. 2), demonstrating a clear time-dependent suppression of molting. Complete molting inhibition was achieved after 4 h of exposure. The LT₅₀ for molting mites exposed to 1% carvacrol was 1.4 ± 0.4 h. Microscopic examination revealed distinct intra-corporeal droplets within the cuticle or intestine of treated molting mites (Fig. 3), which were absent in the paraffin oil control group.
Fig. 2.

The molt rate of Sarcoptes mites following exposure to 1% carvacrol for 1, 2, 3, 4, and 5 h. The control group was treated with liquid paraffin. (****: P < 0.0001; ***: P < 0.001; ns: P > 0.05; error bar represent mean ± SD)
Fig. 3.
Microscopic of molting Sarcoptes mites exposure to solutions (× 400). A the molting mite exposed to paraffin oil. B the molting mite exposed to carvacrol for 3 h. C the molting mite exposed to carvacrol for 5 h. Intra-corporeal droplets are indicated by red arrows
Discussion
The management of S. scabiei infestations remains challenging due to the limited efficacy of current acaricides against molting stages. Exploring natural alternatives with activity across all life stages is therefore crucial. This study represents the first assessment of terpene efficacy against molting Sarcoptes mites. Of the three terpenes tested at the minimum concentration required to achieve 100% mortality of mites within 1 h, carvacrol exhibited superior efficacy against molting mites. Following carvacrol exposure, intra-corporeal droplets were observed within molting mites, suggesting that terpenes likely exert their effects by penetrating the cuticle and carvacrol exhibited greater cuticular penetration efficiency compared to the other two terpenes. Considering its strong efficacy against Sarcoptes mites and their eggs [18, 19], these findings further support carvacrol as a promising natural acaricide candidate.
Carvacrol is a phenolic monoterpenoid abundant in oregano, thyme and wild bergamot [28]. Prior research has validated its acaricidal potency against Psoroptes cuniculi [27], a major ectoparasite of rabbits and other livestock. In a separate study, Senra et al. [26] demonstrated that carvacrol at a concentration of 5.0 μl/ml induced 100% mortality in Amblyomma cajennense larvae and nymphs, while a lower concentration of 2.5 μl/ml was sufficient to achieve complete mortality in Rhipicephalus sanguineus larvae. Eugenol, a key terpenoid predominantly found in Syzygium aromaticum (clove) oil, has been identified as the most potent compound against P. cuniculi mites and their eggs [8]. Beyond P. cuniculi, its acaricidal efficacy has been well-documented against S. scabiei [23] and other economically important ectoparasites, including, Dermanyssus gallinae [29], and various tick [6]. Geraniol has also been shown to exhibit significant bioactivity against a panel of arthropod pests in previous investigations, including mites (D. gallinae and P. cuniculi) [8, 29], ticks [15], and human head lice [12]. These findings collectively confirm that the three terpenes possess broad-spectrum acaricidal activity against a diverse range of arthropod pests.
In a previous study, carvacrol was identified as the most potent among six tested terpenes, exhibiting a lethal time 50% (LT50) of 3.45 min at 1% concentration against Sarcoptes mites [18]. However, the current study revealed that the LT50 for 1% carvacrol on molting mites was 1.4 h, indicating that molting mites are less susceptible than motile stage. This reduced susceptibility is likely due to two key factors associated with the molting process: first, the old cuticle may act as a protective barrier, limiting the penetration of acaricidal compounds [1], and second, mites in a pharate (stationary), non-feeding state have minimal intake of toxins. This same mechanism—combining cuticular protection with reduced exposure explains why molting mites are also less vulnerable to acaricides like ivermectin [9].
The arthropod exoskeleton consists of an outer lipophilic epicuticle and a highly sclerotized exocuticle [16]. Accordingly, highly lipophilic terpenes can diffuse more readily through the lipid-rich integument of mites. The XLogP3 values (calculated using XLogP3 3.0, PubChem release 2025.04.14, https://pubchem.ncbi.nlm.nih.gov) of carvacrol, eugenol, and geraniol are 3.1, 2.0 and 2.9, respectively. Eugenol exhibits the lowest lipophilicity among the three terpenes, suggesting it may have difficulty penetrating the old cuticle of molting mite. In contrast, both carvacrol and geraniol possessed higher lipophilicity, with carvacrol displaying superior acaricidal efficacy. This may be attributed to its higher lipophilicity and more pronounced toxic effect on the mite integument. This finding is supported by L. Guidi et al. [14], who reported that Origanum vulgare essential oil (containing 70.2% carvacrol), when topically administered to the thorax of Calliphora vomitoria flies, acts directly on the body wall due to its lipophilic properties, inducing morphological alterations in the cuticle and integument. Similarly, Lima‐de‐Souza et al.[20] demonstrated a direct toxic effect of carvacrol on the exoskeleton. Sublethal concentrations of carvacrol can penetrate the integument of R. sanguineus s.l. females and alter their morphophysiology.
The exact mechanism by which carvacrol exerts its acaricidal effects on Sarcoptes mites remains unclear. Previous studies have demonstrated that carvacrol can bind to gamma-aminobutyric acid (GABA) and tyramine receptors, disrupting the nervous system of arthropods [13]. This mode of action is particularly effective in impairing neurotransmission and causing paralysis in mites and other pests. Additionally, carvacrol has been found to inhibit acetylcholinesterase (AChE) activity, further impairing neurological function by disrupting acetylcholine metabolism [25]. These dual modes of action may contribute to the high efficacy of carvacrol observed in this study.
A comparative analysis of carvacrol’s efficacy against molting mites and eggs revealed intriguing differences. Approximately 40% of eggs hatched after 12 h of exposure to 1% carvacrol [19], while no molting mites survived after 4 h of exposure at the same concentration. These findings suggest that while molting mites exhibit greater resistance than motile stage, they are less resistant than eggs. This differential susceptibility may be attributed to structural differences, with molting mites possessing a single-layered outer cuticle compared to the multilayered eggshells in eggs, which provide enhanced protection against external agents [3]. Further research is needed to elucidate these structural and biochemical differences and their implications for acaricide efficacy.
Conclusions
Addressing the need for effective treatments against molting stages of S. scabiei, this study investigated the efficacy of three terpenes in the molting stage. Our findings demonstrate that carvacrol, in particular, exhibited significant activity against all key life stages (eggs, molting mites, adult mites).
However, limitation of this study was the limited range of terpene concentrations tested, primarily due to challenges in collecting sufficient numbers of molting mites. Future studies should expand the concentration range to identify optimal dosing strategies and investigate potential synergistic effects with other natural compounds. Additionally, a deeper exploration of carvacrol’s molecular targets and mechanisms of action could provide a clearer understanding of its acaricidal properties and guide the development of more effective formulations. The clinical translation of carvacrol still faces practical challenges, primarily its inherent volatility, which may lead to rapid evaporation from the skin surface and reduced duration of action. To overcome this limitation and ensure sustained contact with the parasite burrowed in the epidermis, future research should focus on advanced formulation strategies. The development of novel delivery systems, such as nano-emulsions, may significantly enhance the stability, skin penetration, and residence time of carvacrol, thereby improving its therapeutic efficacy and practicality for real-world use. Finally, comprehensive safety and in vivo efficacy assessments are essential to evaluate the potential of carvacrol as a treatment option for scabies in humans and sarcoptic mange in animals, ensuring its efficacy and minimizing potential risks.
Acknowledgements
Not applicable.
Authors’ contributions
Siyi Huang wrote the original draft and curated the data. Shenrui Feng performed the formal analysis and contributed to the methodology. Shuyu Liang and Qiyuan Zhou conducted the investigation. Jacques Guillot reviewed and edited the manuscript. Fang Fang acquired funding, supervised the project, and reviewed and edited the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (31902293).
Data availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
The animal samples were collected with the informed consent of the farm owner. All experimentation with animals was approved by the Animal Ethics Committee of Guangxi University (approval number GXU-2020–027).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Arlian LG, Morgan MS, Rider SD. Sarcoptes scabiei: genomics to proteomics to biology. Parasit Vectors. 2016;9:380. 10.1186/s13071-016-1663-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Arul Prakash M, Soundararajan C, Nagarajan K, Tensingh Gnanaraj P, Ramesh Saravanakumar V. Sarcoptic mange infestation in rabbits in an organized farm at Tamil Nadu. J Parasit Dis. 2017;41:429–32. 10.1007/s12639-016-0821-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Beament JWL. The structure and formation of the egg of the fruit tree red spider mite, Metatetranychus ulmi koch. Ann Appl Biol. 1951;38:1–24. 10.1111/j.1744-7348.1951.tb07787.x. [Google Scholar]
- 4.Bernigaud C, Fernando DD, Lu H, Taylor S, Hartel G, Guillot J, et al. In vitro ovicidal activity of current and under-development scabicides: which treatments kill scabies eggs? Br J Dermatol. 2020;182:511–3. 10.1111/bjd.18517. [DOI] [PubMed] [Google Scholar]
- 5.Beugnet F, De Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite. 2016;23:26. 10.1051/parasite/2016026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.de Monteiro CM, Maturano R, Daemon E, Catunda-Junior FEA, Calmon F, de Souza Senra T, et al. Acaricidal activity of eugenol on Rhipicephalus microplus (Acari: Ixodidae) and Dermacentor nitens (Acari: Ixodidae) larvae. Parasitol Res. 2012;111:1295–300. 10.1007/s00436-012-2964-0. [DOI] [PubMed] [Google Scholar]
- 7.Dumitrache MO, Cadiergues M-C. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic. BMC Vet Res. 2023;19:189. 10.1186/s12917-023-03759-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fang F, Li M, Jiang Z, Lu X, Guillot J, Si H. Comparing acaricidal and ovicidal activity of five terpenes from essential oils against Psoroptes cuniculi. Parasitol Res. 2020;119:4219–23. 10.1007/s00436-020-06823-z. [DOI] [PubMed] [Google Scholar]
- 9.Feng S, Shi M, Yin Z, Di W, Guillot J, Fang F. Can Ivermectin kill Sarcoptes scabiei during the molting process? PLoS Negl Trop Dis. 2023;17:e0011337. 10.1371/journal.pntd.0011337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fernando DD, Mounsey KE, Bernigaud C, Surve N, Estrada Chávez GE, Hay RJ, et al. Scabies. Nat Rev Dis Primers. 2024;10:74. 10.1038/s41572-024-00552-8. [DOI] [PubMed] [Google Scholar]
- 11.Fujimoto K, Kawasaki Y, Morimoto K, Kikuchi I, Kawana S. Treatment for crusted scabies: limitations and side effects of treatment with ivermectin. J Nippon Med Sch. 2014;81:157–63. 10.1272/jnms.81.157. [DOI] [PubMed] [Google Scholar]
- 12.Gonzalez-Audino P, Picollo MI, Gallardo A, Toloza A, Vassena C, Mougabure-Cueto G. Comparative toxicity of oxygenated monoterpenoids in experimental hydroalcoholic lotions to permethrin-resistant adult head lice. Arch Dermatol Res. 2011;303:361–6. 10.1007/s00403-010-1110-z. [DOI] [PubMed] [Google Scholar]
- 13.Gross AD, Temeyer KB, Day TA, de Pérez León AA, Kimber MJ, Coats JR. Interaction of plant essential oil terpenoids with the southern cattle tick tyramine receptor: a potential biopesticide target. Chem Biol Interact. 2017;263:1–6. 10.1016/j.cbi.2016.12.009. [DOI] [PubMed] [Google Scholar]
- 14.Guidi L, Grassi E, Petri A, Ascrizzi R, Semprucci F, Rosati C, et al. A look into Calliphora vomitoria after topical treatment with Origanum vulgare essential oil. Eur Zool J. 2025;92:949–62. 10.1080/24750263.2025.2541748. [Google Scholar]
- 15.Khallaayoune K, Biron JM, Chaoui A, Duvallet G. Efficacy of 1% geraniol (Fulltec) as a tick repellent. Parasite. 2009;16:223–6. 10.1051/parasite/2009163223. [DOI] [PubMed] [Google Scholar]
- 16.King, G.F., Hardy, M.C., 2012. Spider-Venom Peptides: Structure, Pharmacology, and Potential for Control of Insect Pests. [DOI] [PubMed]
- 17.Leung AKC, Lam JM, Leong KF. Scabies: a neglected global disease. Curr Pediatr Rev. 2020;16:33–42. 10.2174/1573396315666190717114131. [DOI] [PubMed] [Google Scholar]
- 18.Li M, Feng S, Huang S, Guillot J, Fang F. In vitro efficacy of terpenes from essential oils against Sarcoptes scabiei. Molecules. 2023;28:3361. 10.3390/molecules28083361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Li M, Liu S, Yin Z, Bernigaud C, Guillot J, Fang F. Activity of terpenes derived from essential oils against Sarcoptes scabiei eggs. Parasit Vectors. 2021;14:600. 10.1186/s13071-021-05094-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lima‐de‐Souza JR, De Oliveira PR, Anholeto LA, Sodelli LF, Ferreira ARF, Remedio RN, et al. The bioactive compound carvacrol as a potential acaricide: an assessment of its effects on the integument of female Rhipicephalus sanguineus sensu lato ticks. Microsc Res Tech. 2022;85:1784–90. 10.1002/jemt.24038. [DOI] [PubMed] [Google Scholar]
- 21.Masyita A, Mustika Sari R, DwiAstuti A, Yasir B, RahmaRumata N, Emran TB, et al. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem X. 2022;13:100217. 10.1016/j.fochx.2022.100217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Niedringhaus KD, Brown JD, Sweeley KM, Yabsley MJ. A review of sarcoptic mange in North American wildlife. Int J Parasitol Parasites Wildl. 2019;9:285–97. 10.1016/j.ijppaw.2019.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pasay C, Mounsey K, Stevenson G, Davis R, Arlian L, Morgan M, et al. Acaricidal activity of eugenol based compounds against scabies mites. PLoS ONE. 2010;5:e12079. 10.1371/journal.pone.0012079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Seddiek SA, Khater HF, El-Shorbagy MM, Ali AM. The acaricidal efficacy of aqueous neem extract and ivermectin against Sarcoptes scabiei var. cuniculi in experimentally infested rabbits. Parasitol Res. 2013;112:2319–30. 10.1007/s00436-013-3395-2. [DOI] [PubMed] [Google Scholar]
- 25.Selles, S.M.A., Kouidri, M., González, M.G., González, J., Sánchez, M., González-Coloma, A., Sanchis, J., Elhachimi, L., Olmeda, A.S., Tercero, J.M., Valcárcel, F., 2021. Acaricidal and repellent effects of essential oils against ticks: a review. Pathogens 10. 10.3390/pathogens10111379 [DOI] [PMC free article] [PubMed]
- 26.Senra TOS, Calmon F, Zeringóta V, Monteiro CMO, Maturano R, da Silva Matos R, et al. Investigation of activity of monoterpenes and phenylpropanoids against immature stages of Amblyomma cajennense and Rhipicephalus sanguineus (Acari: Ixodidae). Parasitol Res. 2013;112:3471–6. 10.1007/s00436-013-3527-8. [DOI] [PubMed] [Google Scholar]
- 27.Shang X, Wang Y, Zhou X, Guo X, Dong S, Wang D, et al. Acaricidal activity of oregano oil and its major component, carvacrol, thymol and p-cymene against Psoroptes cuniculi in vitro and in vivo. Vet Parasitol. 2016;226:93–6. 10.1016/j.vetpar.2016.07.001. [DOI] [PubMed] [Google Scholar]
- 28.Sharifi-Rad M, Varoni EM, Iriti M, Martorell M, Setzer WN, del Mar Contreras M, et al. Carvacrol and human health: a comprehensive review. Phytother Res. 2018;32:1675–87. 10.1002/ptr.6103. [DOI] [PubMed] [Google Scholar]
- 29.Sparagano O, Khallaayoune K, Duvallet G, Nayak S, George D. Comparing terpenes from plant essential oils as pesticides for the poultry red mite (Dermanyssus gallinae). Transbound Emerg Dis. 2013;60:150–3. 10.1111/tbed.12138. [DOI] [PubMed] [Google Scholar]
- 30.Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–48. 10.1016/j.jaad.2019.05.109. [DOI] [PubMed] [Google Scholar]
- 31.Tisserand R, Young R. Essential oil safety. Elsevier. 2014. 10.1016/B978-0-443-06241-4.00001-1. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets analyzed during the current study are available from the corresponding author on reasonable request.

